This award recognizes cancer programs that achieve excellence in compliance to the CoC Standards and providing the highest quality care to cancer patients.
Touro Infirmary was recently awarded the 2017 Outstanding Achievement Award by the Commission on Cancer (CoC) of the American College of Surgeons (ACS). Touro is one of a select group of 16 U.S. accredited cancer programs to receive this national honor for cancer surveys performed July 1 – December 31, 2017.
The purpose of the award is to encourage cancer programs to raise the bar on quality cancer care, with the ultimate goal of increasing awareness about high quality, patient-centered care. In addition, the award is intended to:
Touro’s cancer program was evaluated on 34 program standards categorized within five cancer program activity areas: program management, clinical services, continuum of care services, patient outcomes, and data quality. The cancer program was further evaluated on seven commendation standards. To be eligible, all award recipients must have received commendation ratings in all seven commendation standards, in addition to receiving a compliance rating for each of the 27 other standards.
“CoC accreditation is recognized as the gold standard in cancer care. Touro is honored to be among a select few programs nationwide to receive the commission’s 2017 Outstanding Achievement Award” says Susan Andrews, Touro President and Chief Executive Officer. “This elite designation reflects Touro’s commitment to provide the highest level of cancer care for our patients.”
For a list of all cancer programs in the U.S. that received the award during the second half of 2017 visit this section of the ACS website.